PRM-914

N/A

Report date: 2025/07/15 15:05:09
NME

Base Information

Drug NamePRM-914
Drug Alias Name成人隐匿性自身免疫性糖尿病PRM-914PRM914
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucose-dependent insulinotropic receptor agonists
TargetsGlucose-dependent insulinotropic receptor
Therapy Area/IndicationsObesityLatent Autoimmune Diabetes in Adults
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPramana Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesityLatent Autoimmune Diabetes in Adults
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A